Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction-associated steatotic liver disease.
Masahito NakanoMachiko KawaguchiTakumi KawaguchiHitoshi YoshijiPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2024)
ALT levels >30 U/L and MASLD may be involved in the pathogenesis of significant hepatic fibrosis in patients aged ≥65 years.